NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

Labcorp to Acquire Toxikon, Expanding Nonclinical Development Testing Capabilities for Pharmaceutical, Biotech and Medical Device Clients

by Ed Johnson
November 19, 2021
A A

BURLINGTON, N.C.–Nov. 18, 2021– Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Toxikon, a contract research organization delivering best-in-class nonclinical testing services. Once completed, the transaction will create a strategic footprint for Labcorp to partner with pharmaceutical and biotechnology clients in the Boston, Mass., area and bolster its strong nonclinical development portfolio.

“Adding Toxikon underscores our commitment to nonclinical development and advances our capabilities for both drug development and medical device testing,” said Dr. Paul Kirchgraber, CEO of Labcorp Drug Development. “This acquisition extends Labcorp’s portfolio of full-service drug development and medical device solutions from discovery to market approval.”

Toxikon’s strategic location allows Labcorp to further engage with large pharmaceutical companies and biotech firms in the region on nonclinical work, as well as facilitating entry into medical device investigational device exemption (IDE) submissions. As such, Toxikon will also complement Labcorp’s existing nonclinical medical device efficacy and safety testing and the associated clinical work performed by Labcorp’s medical device and diagnostics unit.

Headquartered in Bedford, Mass., and with annual revenues of around $40 million, Toxikon maintains specialized, state-of-the-art facilities and a robust roster of pharmaceutical, biotech and medical device clients. Its highly trained staff provides an extensive portfolio of in vivo and in vitro testing and related consulting services to support life sciences companies. The facility in Bedford also has capacity for growth and provides Labcorp Drug Development with an opportunity to expand its traditional toxicology business.

“As a part of the Labcorp family, we will have an opportunity to broaden our impact through access to extensive resources, knowledge and support,” said Dr. Laxman S. Desai, Toxikon’s founder, president and CEO. “Together, we can provide better outcomes for our clients and, ultimately, the health care providers and patients who depend on our continued success and innovation.”

The transaction is expected to close during the fourth quarter of 2021, subject to customary closing conditions and regulatory approvals, including under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. Specific terms of the transaction were not disclosed.

Tags: < Invest | M&A
ShareTweetShareSend

Related Industries

Healthcare

Azurity Pharmaceuticals Acquires KKR-backed Slayback Pharma

September 28, 2023
Healthcare

Abbott Completes Acquisition of Bigfoot Biomedical

September 23, 2023
Healthcare

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.

September 20, 2023
Healthcare

BD Ranks in Top 10 for Transparency, Awarded Best Code of Conduct in 2023 U.S. Transparency Awards

September 20, 2023
Healthcare

Celanese Announces Agreement with the Population Council for Sustained Release Dual-API Therapeutic

September 13, 2023
Healthcare

Thermo Fisher Scientific and National Minority Quality Forum Collaborate to Make Clinical Research More Accessible to Historically Underserved Communities

September 8, 2023

Abdul Latif Jameel Teams Up With AWS to Power Its Digital Transformation and Signs Renewable Energy Agreement With Amazon

September 20, 2023

...

SABIC AN in collaborative venture with US companies to support Sustainable Agriculture

September 4, 2023

...

Celanese Announces Agreement with the Population Council for Sustained Release Dual-API Therapeutic

September 13, 2023

...

AIG Appoints Patricia J. Walsh as Executive Vice President and General Counsel

September 29, 2023

...

Azurity Pharmaceuticals Acquires KKR-backed Slayback Pharma

September 28, 2023

...

Accelera by Cummins, Daimler Truck and PACCAR form a joint venture to advance battery cell production in the United States

September 8, 2023

...

First HP Work Relationship Index Shows Majority of People Worldwide Have an Unhealthy Relationship with Work

September 21, 2023

...

Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes

September 6, 2023

...

Hilton to Install Up to 20,000 Tesla Universal Wall Connectors at 2,000 Hotels, Creating Largest Overnight Electric Vehicle Charging Network within Hospitality Industry

September 8, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

MENU

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NORTH AMERICAN BUSINESS All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NORTH AMERICAN BUSINESS All rights reserved.